Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic acid

Toxicologic Pathology

Volumn 40, Issue 4, 2012, Pages 682-694

  Betton, Graham R ^a   Ennulat, Daniela ^b   Hoffman, David ^c   Gautier, Jean Charles ^c   Harpur, Ernie ^d   Pettit, Syril ^e  

^a ASTRAZENECA   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c SANOFI   (France)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

Author keywords

biomarkers; collecting duct; degeneration; N phenylanthranilic acid; necrosis; nephrotoxicity; rat; renal papilla necrosis

Indexed keywords

BIOLOGICAL MARKER; CLUSTERIN; CREATININE; EFENAMIC ACID; GLUTATHIONE TRANSFERASE ALPHA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOASSAY; KIDNEY COLLECTING TUBULE; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CLUSTERIN; CREATININE; GLUTATHIONE TRANSFERASE; HISTOCYTOCHEMISTRY; KIDNEY DISEASES; KIDNEY TUBULES, COLLECTING; MALE; NECROSIS; ORGAN SIZE; ORTHO-AMINOBENZOATES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TOXICITY TESTS;

RATTUS; RATTUS NORVEGICUS;

EID: 84861828060     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311436174     Document Type: Article

References (31)

1. Bach P. H., Bridges J. W.. Chemical induced renal papillary necrosis and upper urothelial carcinoma. Part 1. CRC Crit Rev Toxicol. 1985a ; 15: 217-329
2. Bach P. H., Bridges J. W.. Chemical induced renal papillary necrosis and upper urothelial carcinoma. Part 2. CRC Crit Rev Toxicol. 1985b ; 15: 331-441
3. Bach P. H., Nguyen T. K.. Renal papillary necrosis-40 years on. Toxicol Pathol. 1998 ; 26: 73-91
4. Bach P. H., Scholey D. J., DeLaCruz L., Moret M., Nichol S.. Renal and urinary lipid changes associated with acutely induced renal papillary necrosis in the rat. Food Chem Toxicol. 1991 ; 29: 211-19
5. Betton G. R., Falkenberg F. W., Price S., Somers R. L., Roche A.. Immunohistochemical protein expression studies of novel monoclonal kidney biomarkers in the Han Wistar rat. Toxicol Pathol. 2007 ; 35: 187
6. Burkhardt J. E., Ennulat D., Pandher K., Solter P. F., Troth S. P., Boyce R. W., Zabka T. S.. Topic of histopathology blinding in nonclinical safety biomarker qualification studies. Toxicol Pathol. 2010 ; 38: 666-67
7. Burry A.. Pathology of analgesic nephropathy: Australian experience. Kidney Int. 1978 ; 13: 34-40
8. Crissman J. W., Goodman D. G., Hildebrandt P. K., Maronpot R. R., Prater D. A., Riley J. H., Seaman W. J., Thake D. C.. Best practices guideline: Toxicologic histopathology. Toxicol Pathol. 2004 ; 32: 126-31
9. Critical Path Institute (2008 and 2010). Conclusions of the EMA, FDA and PMDA Biomarker Qualification Reviews. Web site of the Critical Path Institute. http://www.c-path.org/PSTCRegulatory.cfm.
10. Dieterle F., Perentes E., Cordier A., Roth D. R., Verdes P., Grenet O., Pantano S., Moulin P., Wahl D., Mahl A., End P., Staedtler F., Legay F., Carl K., Laurie D., Chibout S. D., Vonderscher J., Maurer G.. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 2010 ; 28: 463-69
11. Falkenberg F. W., Hildebrand H., Lutte L., Schwengberg S., Henke B., Greshake D., Schmidt B., Friederich A., Rinke M., Schluter G., Bomhard E.. Urinary antigens as markers of papillary toxicity. I Identification and characterization of rat papillary antigens with monoclonal antibodies. Arch Toxicol. 1996 ; 71: 80-92
12. Gautier J. C., Riefke B., Walter J., Kurth P., Mylecraine L., Guilpin V., Barlow N., Gury T., Hoffman D., Ennulat D., Schuster K., Harpur E., Pettit S.. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin. Toxicol Pathol. 2010 ; 38: 943-56
13. Hardy T. L., Bach P. H.. The effect of N-phenylanthranilic acid-induced renal papillary necrosis on urinary acidification and renal electrolyte handling. Toxicol Appl Pharmacol. 1984 ; 75: 265-77
14. Harpur E., Ennulat D., Hoffman D., Betton G., Gautier J-C., Riefke B., Bounous D., Schuster K., Beushausen S., Guffroy M., Lock E., Pettit S. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. Toxicol Sci. 2011 ; 122: 235-52
15. HESI (2010). Conclusions of the EMA and FDA review of the HESI renal biomarker qualification submission. Website of the Health and Environmental Sciences Institute. http://www.hesiglobal.org/i4a/pages/index.cfm?pageID=3541. Accessed January 20, 2012.
16. Hildebrand H., Rinke M., Schluter G., Bomherd E., Falkenberg F. W.. Urinary antigens as markers of papillary toxicity II Application of monoclonal antibodies for the determination of papillary antigens in rat urine. Arch Toxicol. 1999 ; 73: 233-45
17. Khan K. N. M., Alden C. L., Gleissner S. E., Gessford M. K., Maziasz T. J.. Effect of papillotoxic agents on expression of cyclo-oxygenase isoforms in the rat kidney. Toxicol Pathol. 1998 ; 26: 137-42
18. Lang E. K., Macchia R. J., Thomas R., Davis R., Ruiz-Deya G., Watson R. A., Richter F., Gayle B., Sabel A. L.. Multiphasic helical CT diagnosis of early medullary and papillary necrosis. J Endourol. 2004 ; 18: 49-56
19. Le Hir M., Dubach U. C., Schmidt U.. Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry. 1979 ; 63: 245-51
20. NIH Guide for the Care and Use of Laboratory Animals. NIH Publication. 1996 ; 25 :
21. Price S., Davis D., Rowlinson R., Copley C. G., Roche A., Falkenberg F. W., Riccardi D., Betton G.. Characterization of renal papillary antigen 1 (RPA-1), a biomarker of renal papillary necrosis. Toxicol Pathol. 2010 ; 38: 346-58
22. Rosenberg M. E., Silkensen J. Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol. 1995 ; 27: 633-45
23. Rozell B., Hansson H. A., Guthenberg C., Tahir M. K., Mannervik B.. Glutathione transferases of classes α, μ and π show selective expression in different regions of rat kidney. Xenobiotica. 1993 ; 23: 835-38
24. Sourial S., Searchfield L., Schuppe-Koistinen I., Betton G. R., Riccardi D., Price S. A.. Application of Dolichos biflorus in immunoassay detection of kidney collecting duct biomarkers. Biomarkers. 2010 ; 15: 424-35
25. Stonard M. D., Gore C. W., Oliver G. J., Smith I. K.. Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney. Fundam Appl Toxicol. 1987 ; 9: 339-51
26. Taylor A. N, McIntosh J. E, Bordeau J. E.. Immunocytochemical localization of vitamin D-dependent calcium binding-protein in renal tubules of rabbit, rat and chick. Kidney Int. 1982 ; 21: 765-73
27. Thanh N. T. K., Stevenson G., Obatomi D. K., Aicher B., Baumeister M., Bach P. H.. Urinary lipid changes during the development of chemically-induced renal papillary necrosis; a study using mefenamic acid and N-phenylanthranilic acid. Biomarkers. 2001 ; 6: 417-27
28. Tsuchiya Y., Tominaga Y., Matsubayashi K., Jindo T., Furuhama K., Suzuki K. T.. Investigation on urinary proteins and renal mRNA expression in canine renal papillary necrosis induced by nefiracetam. Arch Toxicol. 2005 ; 79: 500-7
29. UK Home Office Guidelines (Animals [Scientific Procedures] Act1986http://www.homeoffice.gov.uk/science-research/animal-research/
30. Vekaria R. M., Shirley D. G., Sevigny J., Unwin R. J.. Immunolocalization of ectonucleotidases along the rat nephron. Am J Physiol Renal Physiol. 2006 ; 290: F550-60
31. Williams R. E., Cottrell L., Jacobsen M., Bandara L. R., Kelly M. D., Kennedy S., Lock E. A. 1H-Nuclear magnetic resonance pattern recognition studies with N-phenylanthranilic acid in the rat: Time- and dose-related metabolic effects. Biomarkers. 2003 ; 8: 472-90